A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUS ® in Healthy Volunteers

Condition:   Bioequivalence Interventions:   Drug: Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg;   Drug: ADVAIR DISKUS Sponsors:   Respirent Pharmaceuticals Co Ltd.;   BECRO Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials